The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-11.2% to $141.00
Predicted High$158.20in 2 weeks
Predicted Low$141.00at 6 months
Max Drawdown (predicted)-11.2%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 11, 2026 1:19 am
Bear
EMR trends lower to
$141.00
(-11.2% from $158.71)
by Feb 2027.
decay
ThesisEMR trades far above every fundamental anchor with a slightly negative sentiment overlay and weak 6-month momentum, so value gravity should gradually pull the stock lower over the horizon while a risk-on tape cushions the early weeks. No earnings catalyst in window means drift, not shock, dominates. Path decays toward the deterministic baseline near $141 by month six.
Invalidated ifA decisive breakout above $170 on volume, or a beat-and-raise pre-announcement, would invalidate the fade thesis.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $158.71 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 11, 2026
—
$158.71at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 25, 2026
$148.81–$168.61typical range · internal point $158.20
—
±6.2%
6/10
Risk-on tape holds price near current levels short term
1 month
Sep 11, 2026
$144.37–$173.05typical range · internal point $156.50
—
±9.0%
5/10
Mild drift as momentum stays negative, no catalyst
2 months
Oct 11, 2026
$153.00
—
-3.6%
5/10
Valuation gravity begins asserting against stretched multiple
January reset, fundamentals reassert versus rich valuation
6 months
Feb 11, 2027
$141.00
—
-11.2%
4/10
Converges to deterministic baseline near anchored-PE level
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$141.08
(-11.1%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.